IRIS
VERGARO, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.409
EU - Europa 3.388
AS - Asia 693
Continente sconosciuto - Info sul continente non disponibili 21
SA - Sud America 16
AF - Africa 4
OC - Oceania 2
Totale 8.533
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.216
IT - Italia 1.149
GB - Regno Unito 841
UA - Ucraina 357
DE - Germania 352
IE - Irlanda 236
CN - Cina 201
VN - Vietnam 196
CA - Canada 188
SG - Singapore 157
SE - Svezia 148
DK - Danimarca 87
FR - Francia 86
HK - Hong Kong 60
FI - Finlandia 55
PK - Pakistan 29
EU - Europa 20
AT - Austria 15
IN - India 15
PL - Polonia 13
RO - Romania 10
ES - Italia 9
NL - Olanda 9
ID - Indonesia 7
BR - Brasile 5
CH - Svizzera 5
IR - Iran 5
JP - Giappone 5
BD - Bangladesh 4
TH - Thailandia 4
AM - Armenia 3
AR - Argentina 3
CL - Cile 3
HU - Ungheria 3
KZ - Kazakistan 3
RU - Federazione Russa 3
SM - San Marino 3
AU - Australia 2
GH - Ghana 2
MX - Messico 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CO - Colombia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
LT - Lituania 1
NO - Norvegia 1
PA - Panama 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
Totale 8.533
Salva come PNG Salva come JPEG
Città #
Southend 436
Chandler 411
Fairfield 396
San Mateo 309
Woodbridge 293
Houston 254
Dublin 230
Ann Arbor 228
Cambridge 221
Seattle 213
Falls Church 212
Boardman 179
Wilmington 171
Jacksonville 167
Ashburn 166
Ottawa 157
Dearborn 143
Portsmouth 140
Stevenage 136
Dong Ket 108
Beijing 105
Lawrence 101
Pisa 70
Rome 69
Milan 66
Singapore 66
San Diego 45
Florence 44
Fremont 39
Redwood City 35
Helsinki 30
Brooklyn 28
Hong Kong 26
London 26
Washington 25
Assago 24
Central District 20
Padova 20
Bologna 17
Montréal 17
Buti 15
Los Angeles 15
Old Bridge 15
Palermo 15
Genoa 14
Bari 13
Hounslow 13
Norwalk 13
Dallas 12
Islamabad 12
Livorno 12
Redmond 12
Warsaw 12
Lucca 10
Napoli 10
Shanghai 10
Kilburn 8
Nanjing 8
Wandsworth 8
West Jordan 8
Zirl 8
Augusta 7
Brescia 7
Bucharest 7
Forlì 7
Lappeenranta 7
Shenzhen 7
Berlin 6
Cascina 6
Frankfurt am Main 6
Grammichele 6
Jinan 6
Naples 6
Pavia 6
Pescia 6
Taranto 6
Turin 6
Acton 5
Amsterdam 5
Chicago 5
Chiswick 5
Hanover 5
Hyderabad 5
Malang 5
Paris 5
Reggio Calabria 5
Serra 5
Venice 5
Verona 5
Vienna 5
Albavilla 4
Catania 4
Dongguan 4
Foggia 4
Lahore 4
Lyon 4
Medolago 4
Mountain View 4
New Bedfont 4
Parma 4
Totale 5.893
Salva come PNG Salva come JPEG
Nome #
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 562
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 215
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 165
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 158
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 157
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 153
Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice 143
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 142
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 140
Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angiotensinogen polymorphism 139
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 138
Update sui biomarcatori nello scompenso cardiaco. 137
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 137
Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy 126
Cardiac light-chain deposition disease relapsing in the transplanted heart 125
The search for efficient diagnostic and prognostic biomarkers of heart failure 124
Correction of procedural arterial pseudoaneurysms: Established and novel procedures 123
Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible? 121
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 121
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 116
Sex-related differences in chronic heart failure 101
How to take arms against central apneas in heart failure 97
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 95
Heart, kidney and FGF23: Les liaisons dangereuses 94
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 94
Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry 88
High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure 87
Upright Cheyne-Stokes Respiration in Patients With Heart Failure 87
A simple echocardiographic score to rule out cardiac amyloidosis 87
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 85
Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction 84
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 84
Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure 80
[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions 78
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 77
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 76
Management of complications of cardiac amyloidosis: 10 questions and answers 75
N-terminal fraction of pro-B-type natriuretic peptide versus clinical risk scores for prognostic stratification in chronic systolic heart failure 73
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis 72
Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction 71
Left ventricular ejection fraction for risk stratification in chronic systolic heart failure 70
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T 68
Healthy hearts at hectic pace: From daily life stress to abnormal cardiomyocyte function and arrhythmias 67
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study 66
Quality of life and outcome in heart failure with preserved ejection fraction: When sex matters 65
Therapies for cardiac light chain amyloidosis: An update 65
Central And Obstructive Apneas in Heart Failure With Reduced, Mid-Range And Preserved Ejection Fraction. 65
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction 65
The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target? 63
Sex-related differences in chronic heart failure 63
Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome 63
Contribution of the lung to the genesis of cheyne-stokes respiration in heart failure: Plant gain beyond chemoreflex gain and circulation time 63
Wet is bad: Residual congestion predicts worse prognosis in acute heart failure 59
Renin profiling predicts neurohormonal response to sacubitril/valsartan 59
Treatment of cardiac transthyretin amyloidosis: an update 58
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 57
Heart & kidney failure: Who's afraid of renin angiotensin system blockade? 55
Classification of patients with cardiac amyloidosis using machine learning models on Italian electronic clinical health records 54
Atrial amyloidosis: mechanisms and clinical manifestations 53
Longer sleep duration and poor sleep quality as risk factors for hyperlipidaemia 53
Left ventricular ejection fraction and coronary artery disease in the era of precision medicine 52
Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the Week 52
No Aldosterone Breakthrough With the Neprilysin Inhibitor Sacubitril 52
Use of biomarkers to diagnose and manage cardiac amyloidosis 52
Sacubitril–valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction 51
Biomarkers for the diagnosis and management of heart failure 51
Central apnoeas and ticagrelor-related dyspnoea in patients with acute coronary syndrome 51
Biomarkers of heart failure with preserved and reduced ejection fraction 49
Molecular autopsy of sudden cardiac death in the genomics era 49
Role of Imaging in Cardiomyopathies 48
Epidemiological and clinical boundaries of heart failure with preserved ejection fraction 48
In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation 47
Cardiogenic shock and acute kidney injury: the rule rather than the exception 46
Biomarkers for the diagnosis and management of heart failure: New frontiers 45
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure 43
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction 43
Subclinical cardiac damage in cancer patients before chemotherapy 43
Current and emerging drug targets in heart failure treatment 43
Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis 41
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation 41
α-1 Antitrypsin as a potential biomarker in chronic heart failure 41
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 41
Deep-learning-based cardiac amyloidosis classification from early acquired pet images 40
Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance 40
Natriuretic peptides. D'où venons-nous? Que sommes-nous? Où allons-nous? 38
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies 37
Norepinephrine, plasma renin activity and cardiovascular mortality in systolic heart failure 37
NT-proBNP for Risk Prediction in Heart Failure: Identification of Optimal Cutoffs Across Body Mass Index Categories 36
The revolution of ATTR amyloidosis in cardiology: certainties, gray zones and perspectives 35
Cardiac sympathetic denervation in wild-type transthyretin amyloidosis 35
Biomarkers for growth prediction of abdominal aortic aneurysm: A step forward(?) 35
Prognostic value of cardiopulmonary exercise testing in cardiac amyloidosis 35
Cardiac amyloidosis characterization by kinetic model fitting on [18F]florbetaben PET images 34
Safety and efficacy of levosimendan in patients with cardiac amyloidosis 34
PET-CT evaluation of amyloid systemic involvement with [18F]-florbetaben in patient with proved cardiac amyloidosis: a case report 34
Wild type transthyretin amyloidosis: Don't miss diagnosis! 34
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 33
Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure: JACC Review Topic of the Week 33
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 33
Central Apneas Are More Detrimental in Female Than in Male Patients With Heart Failure 33
Totale 7.823
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.719
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201920 0 0 0 0 0 0 0 0 0 0 0 20
2019/2020942 58 31 47 75 123 124 128 61 111 28 43 113
2020/20212.170 157 178 88 197 109 268 188 130 181 146 235 293
2021/20221.826 153 277 75 186 74 66 195 315 137 189 35 124
2022/20231.269 104 107 62 127 157 163 36 116 234 30 79 54
2023/20241.312 72 35 236 100 71 118 101 64 51 75 55 334
Totale 8.731